A Case of Choroidal Osteoma with Subretinal Hemorrhage Improved by Intravitreal Bevacizumab and Aflibercept Injections
Journal of the Korean Ophthalmological Society
; : 989-994, 2018.
Article
in Ko
| WPRIM
| ID: wpr-738475
Responsible library:
WPRO
ABSTRACT
PURPOSE: To report a case of choroidal osteoma (CO) complicated by extensive subretinal hemorrhage treated with intravitreal bevacizumab and aflibercept injections. CASE SUMMARY: A 42-year-old female patient presented with decreased visual acuity and a temporal visual field defect in the left eye. The patient had a history of retinal hemorrhage in the left eye 3 years prior, which improved without any treatment. The patient's visual acuity had decreased to 0.6 at the initial visit. On fundus examination, orange-colored elevated lesions involving the superior peripapillary area with massive subretinal hemorrhage extending to the macular area were revealed. Optical coherence tomography, fluorescein angiography, and B-scan ultrasonography results indicated CO complicated by choroidal neovascularization (CNV). With multiple intravitreal injections of bevacizumab and aflibercept (bevacizumab ×1, aflibercept ×2), the patient's visual acuity improved and the CNV lesion was kept stable without recurrence as of the 1-year follow-up visit. CONCLUSIONS: Intravitreal bevacizumab and aflibercept injections can be helpful in the treatment of CO complicated by CNV, by improving visual acuity and the retinal anatomy.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Osteoma
/
Recurrence
/
Retinaldehyde
/
Retinal Hemorrhage
/
Fluorescein Angiography
/
Visual Acuity
/
Visual Fields
/
Follow-Up Studies
/
Choroid
/
Ultrasonography
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
Language:
Ko
Journal:
Journal of the Korean Ophthalmological Society
Year:
2018
Type:
Article